Related references
Note: Only part of the references are listed.Selective Covalent Targeting of Anti-apoptotic BFL-1 by a Sulfonium-Tethered Peptide
Na Liu et al.
CHEMBIOCHEM (2021)
COVID-19: Discovery, diagnostics and drug development
Tarik Asselah et al.
JOURNAL OF HEPATOLOGY (2021)
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Discovery of small molecule PLpro inhibitor against COVID-19 using structure-based virtual screening, molecular dynamics simulation, and molecular mechanics/Generalized Born surface area (MM/GBSA) calculation
Jie Pang et al.
STRUCTURAL CHEMISTRY (2021)
Crystal structure of SARS-CoV-2 papain-like protease
Xiaopan Gao et al.
ACTA PHARMACEUTICA SINICA B (2021)
COVID-19 challenges and its therapeutics
Sabi Ur Rehman et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
Hadis Fathizadeh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease
Yunxia Xu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery
Ziyang Fu et al.
NATURE COMMUNICATIONS (2021)
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
Mohd Imran et al.
MOLECULES (2021)
Decoding molnupiravir-induced mutagenesis in SARS-CoV-2
Luis Menendez-Arias
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman et al.
BIOMOLECULES (2021)
An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2
Fangfang Yan et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
An Overview of the Epidemiologic, Diagnostic and Treatment Approaches of COVID-19: What do We Know?
Hanieh Beyrampour-Basmenj et al.
PUBLIC HEALTH REVIEWS (2021)
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)
Dae-Gyun Ahn et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Donghyuk Shin et al.
NATURE (2020)
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2
Theresa Klemm et al.
EMBO JOURNAL (2020)
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design
Wioletta Rut et al.
SCIENCE ADVANCES (2020)
Peptide-Drug Conjugate: A Novel Drug Design Approach
Liang Ma et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Peptide-drug conjugates as effective prodrug strategies for targeted delivery
Yin Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
Anna M. Mielech et al.
VIROLOGY (2014)
The Ubiquitin-Conjugating System: Multiple Roles in Viral Replication and Infection
Arianna Calistri et al.
CELLS (2014)
A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
Kiira Ratia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Identification of a novel cleavage activity of the first papain-like proteinase domain encoded by open reading frame 1a of the coronavirus Avian infectious bronchitis virus and characterization of the cleavage products
KP Lim et al.
JOURNAL OF VIROLOGY (2000)